logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Adicet Bio, Inc.

ACET

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity inā€¦ read more

Healthcare

Biotechnology

5 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.81

Price

+0.35%

$0.00

$0.81

Previous Close

$0.80

Open

Premium

52w Discount
Market Cap

$67.685m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$6.506m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$118.636m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.31

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$133.372m

$162.972m

Assets

$29.600m

Liabilities

$15.358m

Debt
Debt to Assets

9.4%

-0.1x

Debt to EBITDA
Free Cash Flow

-$100.253m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.